Diabetes Clinical Trial
Official title:
Family Management of Childhood Diabetes Study
Verified date | November 1, 2019 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will test the effectiveness of a practical, low-cost, problem-solving method
called WE CAN that can be taught to families at diabetes clinics. The goal is to see if this
teaching and support can help with controlling the level of blood sugar in children with type
1 diabetes as they approach adolescence. Attention would go to young people's completion of
tasks necessary to manage diabetes, quality of life, and psychological adjustments, plus the
role of the family in these situations. Type 1 diabetes mellitus, accounting for less than
10% of the disease cases, is marked by the inability of the pancreas to secrete insulin.
People who have it must consistently manage their disease. Successful disease management for
children depends on the family's adaptation to treatment demands. Yet maintaining acceptable
blood sugar control becomes more difficult for adolescents, owing to changes in the body
during that period of life. Also, early adolescence is a vital time in people's development
of health outcomes. The title WE CAN is a way to remember the steps of the problem-solving
method:
- Work together to set goals
- Explore barriers and solutions
- Choose the best solutions
- Act on your plan
- Note the results
Children who have reached age 9 but are not yet 14.5 years who have had type 1 diabetes for
at least 1 year and who have had at least two visits to diabetes clinics at one of four
clinical sites may be eligible for this study. A total of 120 children will participate in
clinic visits once every 3 months.
Participants and their families will attend diabetes clinic visits once every 3 months. They
will be assigned to one of two groups: standard care or WE CAN. Those in the WE CAN group
will have visits about 15 to 45 minutes longer than those involved in the standard care
group. All participants will have two home visits: at the beginning and at 6 months. There
will also be telephone interviews, about 20 minutes long, once every 3 months with the
children and their parents. Medical data will be collected during each visit to the clinic,
including blood samples. A health advisor will work with the families. Questionnaires given
to parents and children separately will measure diabetes-related family conflict, parent
child sharing of responsibilities for the disease, attitudes and emotions about diabetes, and
impact of the disease on the child's life. Also, parents and children together will take part
in a 10-minute discussion of a diabetes-related issue that has caused friction among family
members. They will discuss the problem, come up with possible solutions, and to try to decide
on a solution within 10 minutes. Family discussions will be videotaped at the first home
visit and at the 6-month home visit.
Families in both groups will receive more detailed monitoring of family diabetes management
than is usually the case. Those in the WE CAN group may be able to control diabetes more
effectively during the child's early adolescence, though that result is not guaranteed. If
the family guidance and support provided by the WE CAN health advisor is effective, children
in that group may have better results in blood sugar than they would if they did not
participate in the study. Each family member completing the first and 6-month visits and
completing each telephone interview will receive payment for participating.
Status | Completed |
Enrollment | 1298 |
Est. completion date | August 20, 2009 |
Est. primary completion date | March 1, 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 70 Years |
Eligibility |
- INCLUSION CRITERIA - CHILD CRITERIA: Age 9.0 to 14.5 Type I diabetes diagnosis (diagnosed by ADA criteria) for a minimum of 1 year requiring insulin treatment Insulin dose greater than or equal to 0.5 u/kg/day Mean A1c over last 8 months is less than 13.0% No major chronic diseases (except well-controlled thyroid, asthma) No major visual/auditory impairments Child is not in self-contained special education class throughout the school day No DSM-IV diagnosis of bipolar, addiction, psychosis, or eating disorder documented in existing medical chart. No record of inpatient hospitalization for mental disorder in past six months including substance abuse rehabilitation, eating disorder units or day treatment programs. No history of anti-psychotic medications for the past 6 months. No diagnosis of mental retardation. Literate (reading, writing) in English/Spanish at 2nd grade level Willing to provide informed assent Children who are currently enrolled in any other study (observational or interventional) are not eligible for enrollment. Children cannot enroll in another study during the course of this study. Those who have been in an intervention arm of a trial of a behavioral, psychological or psychoeducational intervention and concluded their study follow-up within the past 12 months are also ineligible to participate. However, children who were in a standard care control group in an intervention study or who were in an observational study are eligible once they have completed all scheduled study follow-ups. PARENT/FAMILY ENVIRONMENT CRITERIA: Child lives in geographically stable home, no multiple foster homes, boarding school, or institutions expected to next 2 years. The same 1 or 2 adult caregivers have accompanied the child to every diabetes clinic visit in the past year, and a single adult, who has primary responsibility for the child's diabetes care and monitoring, agrees to participate in all aspects of the protocol (single-parent families, blended families and separated parents will be eligible). Family has no plan to re-locate out of area within the next 2 years of the study. Home has telephone access Primary parent is not currently undergoing treatment for substance abuse. Primary parent has not been hospitalized in past 6 months for mental disorder. Primary caretaker has no history of psychosis. Child had at least 2 clinic visits within last 12 months Parent and child wiling to come to clinic every 3 months for duration (2 years) of study. Families who are currently enrolled in any other study (observational or interventional) are not eligible for enrollment. Families cannot enroll in another study during the course of this study. Those who have been in an intervention arm of a trial of a behavioral, psychological or psychoeducational intervention and concluded their study follow-up within the past 12 month are also ineligible to participate. However, families who were in a standard care control group in an intervention study or who were in an observational study are eligible once they have completed all scheduled study follow-ups. If a family has more than one eligible child, all qualifying children who provide consent/assent will participate in assessment and intervention or control activities; however, only the oldest qualifying child will be included in statistical analyses. |
Country | Name | City | State |
---|---|---|---|
United States | Joslin Diabetes Center | Boston | Massachusetts |
United States | Childrens Memorial Hospital, Chicago | Chicago | Illinois |
United States | Texas Children's Hospital | Houston | Texas |
Lead Sponsor | Collaborator |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Allen DA, Tennen H, McGrade BJ, Affleck G, Ratzan S. Parent and child perceptions of the management of juvenile diabetes. J Pediatr Psychol. 1983 Jun;8(2):129-41. — View Citation
Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986 Jul 24;315(4):215-9. — View Citation
Anderson BJ, Brackett J, Ho J, Laffel LM. An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control. Diabetes Care. 1999 May;22(5):713-21. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |